2004•Mebio oncologyRequires access

Oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment for colon cancer.Andre T,et al.for Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.N Engl J Med 2004;350:2343-51.PMID:15175436--大腸癌の術後補助化学療法で、初めて多剤併用療法の優越性を証明した注目すべき試験

順子岩崎, 敦大津

Open publisher page 23 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 23 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Oxaliplatin, Fluorouracil, Medicine, Colorectal cancer, Adjuvant, Internal medicine, Oncology, Cancer

Back to paper search Browse research topics Original source

Oxaliplatin,fluorouracil,and leucovorin as adjuvant treatment for colon cancer.Andre T,et al.for Multicenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC) Investigators.N Engl J Med 2004;350:2343-51.PMID:15175436--大腸癌の術後補助化学療法で、初めて多剤併用療法の優越性を証明した注目すべき試験 — Research Paper | ScholarLens